Fatty acid-binding protein 4 impairs the insulin-dependent nitric oxide pathway in vascular endothelial cells

Different association of circulating levels of adipocyte and epidermal fatty acid-binding proteins with metabolic syndrome and coronary atherosclerosis in Chinese adults

(2011) Jie Hong et al.   ATHEROSCLEROSIS

Association of increased plasma adipocyte fatty acid-binding protein with coronary artery disease in non-elderly men

(2011) Masayuki Doi et al.   Cardiovascular Diabetology

Heart-Type Fatty Acid Binding Protein (H-FABP): Relationship with arterial ıntima-media thickness and role as diagnostic marker for atherosclerosis in patients with ımpaired glucose metabolism

(2011) Basak Karbek et al.   Cardiovascular Diabetology

Small artery dilation and endothelial markers in cardiovascular risk patients

(2011) Gemma Aragonès et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Small-molecule inhibitors of FABP4/5 ameliorate dyslipidemia but not insulin resistance in mice with diet-induced obesity

(2011) Hong Lan et al.   JOURNAL OF LIPID RESEARCH

Fatty acid-binding protein 4 is associated with endothelial dysfunction in patients with type 2 diabetes

(2010) Gemma Aragonès et al.   ATHEROSCLEROSIS

Chronic administration of BMS309403 improves endothelial function in apolipoprotein E-deficient mice and in cultured human endothelial cells

(2010) Mary YK Lee et al.   BRITISH JOURNAL OF PHARMACOLOGY

FABP4 plasma levels are increased in familial combined hyperlipidemia

(2010) A. Cabre et al.   JOURNAL OF LIPID RESEARCH

Endothelial dysfunction in diabetes mellitus: Molecular mechanisms and clinical implications

(2010) Corey E. Tabit et al.   REVIEWS IN ENDOCRINE & METABOLIC DISORDERS

Adipocyte Fatty Acid–Binding Protein Suppresses Cardiomyocyte Contraction

(2009) Valéria Lamounier-Zepter et al.   CIRCULATION RESEARCH

Plasma fatty acid binding protein 4 is associated with atherogenic dyslipidemia in diabetes

(2008) Anna Cabré et al.   JOURNAL OF LIPID RESEARCH

The fatty acid binding protein-4 (FABP4) is a strong biomarker of metabolic syndrome and lipodystrophy in HIV-infected patients

(2007) Blai Coll et al.   ATHEROSCLEROSIS